Vedolizumab dose escalation as a way of recapturing response in patients with inflammatory bowel disease

被引：0
|
作者：
Sierra Morales, M. [1 ,2 ]
Birdi, S. [1 ]
Samaan, M. A. [1 ]
Brown-Clarke, C. [1 ]
Duncan, J. [1 ]
Stanton, A. [1 ]
Koumoutsos, I. [1 ]
Anderson, S. [1 ]
Ray, S. [1 ]
Mawdsley, J. [1 ]
Sanderson, J. [1 ]
Irving, P. M. [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England
[2] Hosp Univ Ramon & Cajal, Gastroenterol & Hepatol, Madrid, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P673
引用
收藏
页码：S451 / S452
页数：2
相关论文
共 50 条
  • [41] Bringing the Mucosa to Heal With Vedolizumab in Patients With Inflammatory Bowel Disease
    Aniwan, Satimai
    Loftus, Edward V., Jr.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (09): : 1030 - 1031
  • [42] Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Dahiya, Dushyant Singh
    Chandan, Saurabh
    Bapaye, Jay
    Mohan, Babu P.
    Ramai, Daryl
    Kassab, Lena L.
    Chandan, Ojasvini C.
    Dulai, Parambir S.
    Kochhar, Gursimran S.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (04) : 378 - 388
  • [43] Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease
    Navaneethan, Udayakumar
    Edminister, Timothy
    Zhu, Xiang
    Kommaraju, Kiran
    Glover, Sarah
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (04) : E17 - E17
  • [44] Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Saleh, Adam
    Wang, Lin
    Ezeana, Chika
    Wong, Stephen
    Perry, Caroline
    Abraham, Bincy
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (02) : 91 - 99
  • [45] ARTICULAR MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Nocturne, Gaetane
    Seror, Raphaele
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1240 - 1241
  • [46] Variability in Vedolizumab Exposure between Patients with Inflammatory Bowel Disease
    Gils, A.
    Dreesen, E.
    Peeters, M.
    Brouwers, E.
    Ferrante, M.
    Van Assche, G.
    Vermeire, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S91 - S91
  • [47] Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis
    Courtney Perry
    Kyle Fischer
    Ahmed Elmoursi
    Cody Kern
    Alden Currier
    Praneeth Kudaravalli
    Olalekan Akanbi
    Nishant Tripathi
    Pradeep Yarra
    Leon Su
    Deborah Flomenhoft
    Arnold Stromberg
    Terrence A. Barrett
    [J]. Digestive Diseases and Sciences, 2021, 66 : 2051 - 2058
  • [48] MUSCULOSKELETAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Rodriguez-Merlos, P.
    Ruiz-Ramirez, M. A.
    Plasencia, C.
    Navarro-Compan, V.
    Suarez-Ferrer, C.
    Martin-Arranz, E.
    Martin Arranz, M. D.
    Peiteado, D.
    Bonilla, G.
    Sanchez Azofra, M.
    Poza Cordon, J.
    Franco Gomez, K. N.
    Balsa, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 731 - 732
  • [49] The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease
    Kamal, Natasha
    Marciano, Beatriz
    Curtin, Bryan
    Strongin, Anna
    DeRavin, Suk See
    Bousvaros, Athos
    Koh, Christopher
    Malech, Harry L.
    Holland, Steven M.
    Zerbe, Christa
    Heller, Theo
    [J]. GASTROENTEROLOGY REPORT, 2020, 8 (05): : 404 - 406
  • [50] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
12345